Hi Jdmoney,
If big pharma show the money in a race to secure Clarity, timing will be when they see as long enough. It is big pharma that want their name on the approval on completion of the trial, not Clarity's. I do agree it would be great to see this company (as many others have eluded too on this forum) evolve the technology to more of the potential it has.
In the interview with Mark Bouris one key point was they spoke about being focused on 1 thing, and not get distracted by the many other opportunities that exist. Clarity do seem very focused on the Prostate assets. Will it be cooked enough this year or next? We will have to wait and see. Your a next year sort of guy and I am a this year sort of guy.
Best Regards
Research/Valuation, page-99
-
- There are more pages in this discussion • 498 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.85 |
Change
-0.450(7.14%) |
Mkt cap ! $1.833B | |||
| Open | High | Low | Value | Volume |
| $6.30 | $6.45 | $5.65 | $10.87M | 1.793M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1417 | $5.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.86 | 1255 | 5 |
View Market Depth
| Last trade - 14.09pm 16/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |